Other safety alerts
|
| |
| World Health Organization: Medical Product Alert: Falsified emergency contraceptive circulating in East Africa – Postinor-2 |
| |
This Medical Product Alert relates to the confirmed circulation of falsified versions of Postinor-2 (Levonorgestrel) in East Africa.
Postinor-2 is a widely used emergency contraceptive that should contain 0.75mg of levonorgestrel. The genuine product is manufactured by Gedeon Richter.
In August 2015, the Uganda National Drug Authority notified World Health Organization (WHO) of the seizure of falsified Postinor-2 discovered in Kampala, Uganda. All packs reported bear the same batch number and expiry/manufacturing dates.
The details of the product are as follows:
Product Name: Postinor-2
Batch Number: T38012
Manufacturing Date: 08 2013
Expiry Date: 08 2018
There is a non-useable white “scratch area” on the reverse side of the pack. The packaging is in English, French and Spanish languages.
The batch number and manufacturing/expiry dates relate to a genuine batch of Postinor-2. Laboratory analysis has shown that the product contains zero active pharmaceutical ingredient. Furthermore, the manufacturers of genuine Postinor-2 have confirmed the packaging is falsified.
Please refer to the following website in WHO for details:
http://www.who.int/../Alert5_2015_FalsifiedPostinor_EN.pdf?ua=1
In Hong Kong, Postinor-2 Tab 0.75mg (HK-49747) is a pharmaceutical product registered by Mekim Ltd (Mekim) and manufactured by Gedeon Richter PLC. It is a prescription-only medicine. So far, the Department of Health (DH) has not received any adverse drug reaction case related to the product. As confirmed with Mekim, the affected batch (T38012) has not been imported into Hong Kong. The registered packing of the product is also different from that of the falsified product. DH will remain vigilant on the update of the incident.
Ends/ Thursday, November 19, 2015
Issued at HKT 14:00
|
| |
